Giving Thanks
Dr. Leap reminds us about the importance of gratitude, even for the mundane.
Bird Flu is Here for Thanksgiving
An outbreak of highly pathogenic avian influenza has spread through chicken and turkey flocks since it was first detected in ...
Income Uncertainty Drives Coverage Gap
More than 2 million low-income people — mostly in Florida and Texas — are uninsured because they are stuck in ...
DEA Sets CDC Opioid Guidelines
The CDC unveiled its latest opioid prescribing guidelines. It's decidedly more patient centric, but fails to account for how law ...
Declare Pandemic Uncertainty
Enough time has passed to where we are reflecting on the pandemic for a sense of closure. We would be ...
Arc of Medicare Advantage Plans
Medicare Advantage plans are facing scrutiny after years of excessive billing practices. The fraud exemplifies how delivery models cannot align ...
Resources to See Which Hospitals Are Penalized by Medicare
The federal government cuts payments to hospitals that have high rates of readmissions and those with the highest numbers of ...
Election Results Support Abortion Rights
The first major election since the Supreme Court overturned Roe v. Wade saw abortion rights on the ballot in a ...
Long COVID Patients Short on Medical Support
The long waits for disability assistance often end in denial, because patients don’t have the medical evidence that federal officials ...
Pfizer’s COVID Cash Payout
For drugmaker Pfizer, a fortune amassed in the pandemic is now paving the path to pharma nirvana: a drug innovation ...
HIPAA Hinders Gun Advocacy
HIPAA was designed to protect patient rights. But for victims of gun violence and the advocates who help them, it ...
Biased Coverage of Gun Violence
Journalists often portray gun violence through familiar patterns of writing. This format misrepresents the full story of those involved.
FDA Evaluation of Certain Bulk Drug Substances in Compounding: Clinical Interpretation
Clinicians increasingly encounter patients using or requesting peptide-based therapies sourced through compounding pharmacies. The U.S. Food and Drug Administration has identified a subset of bulk drug substances, including certain peptides, that may present significant safety risks when used in compounded formulations. The clinical question is whether these regulatory signals reflect meaningful patient-level risk and how they should influence prescribing behavior. This matters because compounded peptides often sit outside traditional approval pathways, creating uncertainty around quality, dosing consistency, and safety. Understanding...
Read morePopular
-
Drug Pricing Transparency in an Era of Political Polarization: What MedPricer’s Data Reveals About a Contested Policy Landscape
-
Employer-Sponsored Insurance Is Breaking Down. Price Data Tells You Where It’s Happening First.
-
The Importance of Access Control in the Workplace
-
State Regulators and the Federal Data Gap: How MedPricer Fills What CMS Leaves Incomplete
-
Chronic Care Toolbox
